Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Aliment Pharmacol Ther. 2017 Jul 10;46(6):581–588. doi: 10.1111/apt.14214

Table 1.

Demographics, psychosomatic scores and quantitative data on bile acid diarrhoea serum markers (BSFS: Bristol Stool Form Scale; HAD: Hospital Anxiety and Depression Scale)

Mean ± SD IBS-D/Chronic diarrhoea
N 101
IBS-D/functional diarrhoea 84 / 17
Age (yrs) 42.2 ± 12.9
Gender (F/M) 85/16
BMI, kg/m2 28.7 ± 7.4
Bowel movements/day 2.2 ± 1.2
Bowel consistency (BSFS) 4.7 ± 1.0
Anxiety score (HAD) 4.5 ± 2.9
Depression score (HAD) 1.6 ± 1.7
Abdominal surgery (# of patients)
 Hysterectomy 13
 Cholecystectomy 14
 Appendectomy 10
Fasting serum C4 (ng/mL) 23.5 ± 23.1
Number with C4 ≥52.5ng/mL 10/101 (10%)
Fasting serum FGF19 (pg/mL) 121.6 ± 84.22
Number with FGF19 ≤61.7pg/mL 21/100 (21%)